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Purpose: To evaluate the clinical, histopathologic, and genetic characteristics of a microphthalmia pedigree.
Methods: A five-generation Chinese family with microphthalmia was recruited. Clinical and histological examinations
were performed in the affected patients and their family members. Cyrillic software was used to map the pedigree. Genomic
DNA was extracted from peripheral blood, and linkage analysis was performed using short tandem repeat polymorphism
markers. Two-point LOD scores were calculated using the MLINK program.
Results: Microphthalmia was inherited in an autosomal dominant manner in this family. All nine affected members had
hyperopia (mean: +8.00 diopters) and physiologically reduced axis oculi (mean: 19.29 mm) with a visual acuity of less
than 0.5. Refractory angle-closure glaucoma occurred in three of them and atrophia bulbi in two. Histological examination
showed diffuse degenerated collagen fibers in the scleral stroma. Two-point LOD score linkage analysis excluded all
known genetic loci associated with simple microphthalmia in all patients.
Conclusions: Simple microphthalmia was dominantly inherited in this Chinese pedigree with typical phenotypes, which
resulted in severe visual deterioration by middle age. A novel locus is predicted to be responsible for the microphthalmia
in this family, which may prove a high genetic heterogeneity in microphthalmia.
Simple microphthalmia (OMIM 309700), which refers to
a structurally normal but small eye globe, is an uncommon
congenital  or  developmental  ocular  anomaly.  Absent  of
systemic disease, it is usually bilateral with a short axis and
has hyperopia of +7.00 to +13.00 diopters, a high volume ratio
of lens to eye, and a high incidence of angle-closure glaucoma
[1,2]. Hyperopia can be treated with correcting lenses, but
some  children  may  develop  irreversible  amblyopia  if  not
diagnosed in time. Untreated angle-closure glaucoma is prone
to result in blindness. However, complications are common
in microphthalmic eyes after any type of intraocular surgery,
especially  interventions  for  glaucoma,  which  may  cause
severe  loss  of  vision  [3].  Moreover,  microphthalmia  is  a
clinically heterogeneous developmental disorder. As major
causative genes for simple microphthalmia, CHX10 (Ceh10
homeodomain gene; OMIM 142993), PAX6 (Paired box gene
6;  OMIM  607108),  and  MFRP  (Membrane-type  frizzled-
related protein; OMIM 606227) probably induce the failure
of ocular differentiation [4-6]. In addition to these putative
genes, several loci have been identified with microphthalmia,
mapping to chromosomes 11p, 14q32, and 2q11-q14 [2,7,8].
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It has been reported that 3.2%–11.2% of blind children
suffered from microphthalmia [9]. The prevalence rate was
1.18/10,000 births in China [10], which is similar to that in
the  Caucasian  population  in  England  [11].  There  was  no
predilection  with  regard  to  race  and  gender  [12].  Most
microphthalmos cases were sporadic, and a small quantity of
cases were inherited in an autosomal dominant or recessive
fashion [13]. In this study, we reported a Chinese family with
a dominant form of simple microphthalmia and found that
there may be a high genetic heterogeneity in microphthalmia.
METHODS
Clinical  examinations:  A  five-generation  Chinese  family
diagnosed with microphthalmia was recruited at Shandong
Eye Institute (Qingdao, China). The research followed the
tenets of the Declaration of Helsinki. All 34 family members
underwent  general  physical  and  complete  ophthalmic
examinations including refraction, corneal curvature and axial
length  by  A-B  scan  ultrasonography,  slit-lamp
biomicroscopic examination, the measurement of intraocular
pressure, gonioscopic examination, and optic-disc evaluation.
Histological examination: Whole eye globes or full-thickness
scleras obtained from the affected members during surgery
were subjected to light microscopic evaluation (Eclipse E800;
Nikon, Tokyo, Japan). Samples were fixed for 12 h in 4%
neutral formaldehyde (pH 7.4). After repeated washing in
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949water, a prolonged dehydration in a graded series of ethanol
and  an  immersion  with  toluene  and  paraffin  wax  were
performed. Samples were then immersed in prepolymerized
epoxy resin and embedded in paraffin wax. Four-micrometer
sections were prepared and stained with hematoxylin and
eosin.
Karyotype analysis: Chromosomes of actively proliferating
peripheral blood lympholeukocyte cultures were analyzed.
Cells in the exponential phase of growth were treated with
0.06 μg/ml colchicine at 37 °C for 3 h before being collected
and incubated in a hypotonic salt solution (0.075 M KCl) at
37 °C for 20 min. After the cells were subsequently fixed in
cold methanol/acetic acid (3:1 v/v), 1 ml of dispersed cell
suspension was smeared evenly on a cold slide, air dried,
stained with Giemsa, and observed using a microscope.
Linkage  analysis:  Genomic  DNA  isolated  from  3  ml  of
peripheral  blood  using  the  routine  phenolic  alcohol-
chloroform method [14] was diluted to a concentration of 100
ng/ml. Thirty-four individuals including nine affected family
members and 25 unaffected family members were collected
and subjected to further analysis. Multiple polymerase chain
reaction  (PCR)  amplifications  were  performed  using
AmpliTaq Gold DNA polymerase (PE Applied Biosystems,
Foster  City,  CA)  in  15  ml  of  reaction  mixtures  with  a
touchdown procedure. The 23 microsatellite repeat markers
for assay were from five autosomes (ABI PRISM Linkage
Mapping Panels; PE Applied Biosystems). One of each pair
of primers was labeled with phosphoramidite fluorescent tags.
Thermal  cycling  in  the  Amplifier  2720  (PE  Applied
Biosystems) was performed. The resulting PCR products were
analyzed on an ABI 3100 semiautomated sequencer. GS400
size standards were used as internal standards. Alleles read
and  scored  with  Genescan  and  Genotyper  software  (PE
Applied Biosystems) were confirmed by visual inspection,
and two-point LOD scores were calculated using the MLINK
sub-program from the LINKAGE package of programs under
a  model  of  autosomal  dominant  inheritance  with  95%
penetrance  and  a  disease-allele  frequency  of  0.0001.  The
recombination frequencies between male and female were
assumed  equal.  Allele  frequencies  for  all  markers  were
calculated from an ethnically matched population.
RESULTS
Phenotype:  All  family  members  did  not  have  any  other
physical anomalies. Nine microphthalmia patients from the
ages of 6–66 years (mean: 42.8 years) expressed the same full
phenotype as previously reported [2,9]. They were affected
by  isolated  microphthalmia  in  an  autosomal  dominant
transmission  manner  in  both  eyes  with  onset  since  birth
(Figure 1). Combined hyperopia ranged from +4.50 to +11.50
diopters (mean: +8.00 diopters). The axial length was from
18.22 mm to 20.26 mm (mean: 19.29 mm), which was shorter
than the normal length of 23–24 mm. Best corrected visual
acuity was less than 0.5 in most eyes. Angle-closure glaucoma
or occludable anterior chamber angles were present in three
patients who were all older than 50 years of age and was
treated by trabeculectomy, but the pathogenetic condition kept
developing. In the end, atrophia bulbi occurred in subjects
III10 and III15 despite repeated surgeries (Table 1).
Impairment  of  the  global  structure:  The  histological
examination  showed  that  the  full-thickness  scleras  were
composed of collagen fibers and fibroblasts. The diffusely
Figure  1.  The  pedigree  of  a  five-
generation  Chinese  family  with
autosomal  dominant  microphthalmia.
The  symbols  in  the  image  are;  open
circle=female;  open  square=male;
closed  circle=affected  female;  closed
square=affected male; open square with
backslash=deceased male; closed circle
with  backslash=deceased  female;  and
open  square  with  question  mark;
possible affected male.
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950swelled collagen fibers were twisted or frayed and were mixed
with normal fibers (Figure 2A). In the two atrophied globes,
which became significantly smaller than the other affected
eyes but maintained a relatively normal shape, the alignment
of collagen fibers was disrupted and there were a lot of coil-
like amorphic materials in the scleras with three times the
thickness of a normal sclera. The corneas were thickened as
well. The pigment cells proliferated, and bone-like tissues
were formed in the eyes (Figure 2B).
Genetic analysis: The karyotype in the nine affected family
members was normal. Two-point LOD scores indicated that
all 23 markers were less than 1 under different recombination
fractions (Table 2).
DISCUSSION
Congenital  microphthalmia  is  rare  and  results  in  severe
developmental defects of eye globes. Up to 80% of affected
individuals  are  accompanied  by  physical  congenital














III10/F/66 OD: NLP − 4.96 ↑ +/60 46,XX
  OS: FC/30cm +10.00/18.27 4.94 ↑ +/59
III11/M/60 OD: 0.5 +9.00/19.28 4.58 − − 46,XY
  OS: 0.2 +9.50/19.19 4.56 ↑ +/58
III14/F/56 OD: 0.5 +10.50/18.47 5.17 − − 46,XX
  OS: 0.2 +11.50/18.40 5.13 − −
III15/M/53 OD: 0.2 −/18.22 4.98 ↑ +/52 46,XY
  OS: NLP − 4.96 ↑ +/52
III17/M/50 OD: 0.5 +6.50/19.98 4.88 − − 46,XY
  OS: 0.3 +6.50/19.91 4.90 − −
IV10/M/40 OD: 0.5 +8.00/19.78 4.03 − − 46,XY
  OS: 0.5 +8.50/19.66 4.05 − −
IV19/M/28 OD: 0.8 +4.50/20.25 4.03 − − 46,XY
  OS: 0.8 +4.50/20.26 3.99 − −
IV21/M/27 OD: 0.8 +4.50/20.12 3.98 − − 46,XY
  OS: 0.8 +4.50/20.16 4.01 − −
V5/M/6 OD: 0.3 +9.00/19.59 3.54 − − 46,XY
  OS: 0.3 +8.50/19.63 3.58 − −
All affected members had hyperopia and physiologically reduced axis oculi with a visual impairment. FC=finger count; NLP=No
light perception; Lens A-PD=Lens antero-posterior diameter; IOP=intraocular pressure.
Figure 2. Histological examination of the paraffin sections stained with hematoxylin and eosin. A: The diffusely swelled collagen fibers were
twisted or frayed (arrows) and mixed with normal fibers in the sclera (Subject III15; magnification, 400X). B: The alignment of collagen
fibers was disrupted, and there were a lot of coil-like amorphism materials (arrows) in the sclera of an atrophied eye globe (Subject III10;
size, 20 mmx18 mmx15 mm; magnification, 100X).
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951malformations  (multiple  malformations)  as  well  as  other
ocular  abnormalities  such  as  coloboma,  orbital  cyst,  and
cataract  [15].  Isolated  microphthalmia  is  an  uncommon
condition. Data on these malformations have been scarcely
reported, and most cases have been of unknown etiology. In
this study, we evaluated an isolated microphthalmia pedigree
of Chinese origin. The diagnosis was based upon clinical and
imaging criteria and confirmed by histology of the sclera.
Establishing  a  phenotype  of  this  pedigree  involved
undertaking  a  comprehensive  family  and  medical  history,
physical examination, imaging, karyotyping, and molecular
genetic testing. The disease pattern was autosomal dominant
in  this  family  with  nine  members  affected  with
microphthalmia. Most patients had serious visual impairment.
An unusually high incidence of high hyperopia and frequent
occurrence of angle-closure glaucoma were noted. Hyperopia
in  these  affected  members  was  congenital.  Complicated
glaucoma at middle age represented a late stage of progression
of the phenotype. Both were attributed to congenital short
ocular  axis.  These  patients  experienced  a  high  rate  of
complications  and  blindness  after  intraocular  surgery,
including two with final atrophia bulbi. Learning disabilities
were observed in one-third of the cases. The lens thickening
after  middle  age  and  the  gradually  occludable  anterior
chamber angles could generate refractory glaucoma. In the
end, loss of visual acuities would occur in most patients.
The  detailed  pathogenesis  of  microphthalmia  remains
unknown. In the present study, the scleras were subjected for
ultrastructural examination. Histologically, collagen fibers in
the  scleral  stroma  degenerated,  and  the  sclera  became
significantly thickened compared to the report of Fukuchi et
al. [16]. It is possible that the abnormal collagen fibers directly
prevented the early development of eye globes. The atrophied
eye globes were obviously small in size, the pigment cells
proliferated,  bone-like  tissue  formed,  and  calcification
occurred.  These  features  were  consistent  with  typical
microphthalmia.
Moreover,  congenital  microphthalmia  is  usually
combined with anterior segment dysgenesis [16] and raised
intraocular  pressure,  which  may  result  from  eye
embryological  defects.  According  to  Mann  [17],
anophthalmia had its genesis early in gestation as a result of
the failure to develop the anterior neural tube (secondary
anophthalmia) or optic pits to enlarge and form optic vesicles
(primary  anophthalmia).  The  genes  that  regulated  eye
embryogenesis  induction  failure  could  be  responsible  for
microphthalmia.  Abnormal  migration  or  proliferation  of
neural crest cells has been implicated in the development of
several anterior segment anomalies and congenital glaucoma
syndromes  [18,19].  However,  the  posterior  segment  of
microphthalmic eyes seems to be more frequently affected
than the anterior. Weiss et al. [20] reported that postnatal
ocular growth was crucial. The decreased size of the optic cup,
altered proteoglycans in the vitreous, low intraocular pressure,
and abnormal growth factor production may all or in part have
a bearing on the pathogenesis of simple microphthalmia while
inadequate production of secondary vitreous may result in
complex microphthalmia.
TABLE 2. TWO-POINT LOD SCORE LINKAGE ANALYSIS WITH KNOWN GENETIC LOCI IN ALL PATIENTS.
Marker Position
Recombination fraction
0 0.01 0.05 0.1 0.2 0.3 0.4
D2S2216 2p11.2-q14.3 −3.30 −0.03 0.55 0.69 0.65 0.45 0.21
D2S160   −18.86 −6.86 −3.77 −2.39 −1.10 −0.48 −0.15
D2S112   −11.99 −6.55 −3.52 −2.17 −0.93 −0.35 −0.08
D2S347   −0.22 −0.22 −0.2 −0.18 −0.14 −0.07 −0.02
D3S1285 3p14.1-p12.3 −5.05 −2.58 −1.64 −1.10 −0.50 −0.19 −0.04
D3S3681   −7.94 −4.46 −2.12 −1.10 −0.25 0.04 0.07
D11S4046 11p15.5-q23.3 −13.67 −3.29 −1.34 −0.63 −0.13 −0.01 −0.03
D11S902   −18.22 −7.62 −4.05 −2.54 −1.17 −0.51 −0.16
D11S904   −9.61 −3.47 −1.36 −0.54 0.07 0.21 0.15
D11S935   −8.95 −2.45 −0.55 0.09 0.44 0.38 0.17
D11S905   −9.28 −1.16 0.04 0.39 0.45 0.25 0.04
D11S4191   −5.47 −1.89 −0.62 −0.19 0.07 0.11 0.07
D11S987   −4.91 −2.06 −0.79 −0.34 −0.05 0.00 0.00
D11S1314   −9.84 −2.60 −0.73 −0.11 0.18 0.08 −0.05
D11S908   −6.10 −3.44 −1.49 −0.76 −0.21 −0.04 0.00
D11S925   −5.57 −1.35 0.03 0.50 0.68 0.50 0.20
D14S258 14q24.2-q32.12 −10.86 −3.68 −1.55 −0.70 −0.05 0.12 0.09
D14S985   −10.10 −3.18 −1.66 −0.99 −0.39 −0.13 −0.01
D14S292   0.54 0.53 0.48 0.41 0.26 0.14 0.05
D14S280   −5.46 −1.87 −0.97 −0.53 −0.15 −0.02 0.00
D15S165 15q13.3-q14 0.12 0.11 0.09 0.07 0.04 0.02 0.00
D15S1007   −11.74 −3.51 −1.39 −0.57 0.02 0.14 0.08
D15S1012   −10.57 −3.25 −1.74 −1.09 −0.51 −0.25 −0.10
All 23 markers were less than 1 under different recombination fractions.
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952Regarding genetic analysis, chromosomal abnormality is
usually implicated in microphthalmia with syndromes. The
karyotype in this pedigree was normal, so the disease was most
probably induced by a mutation of a monogenic mutation.
Moreover,  genetic  defects  that  underlie  the  autosomal
dominant microphthalmia are still unclear. Microphthalmia
has been mapped to different chromosomal regions [21], but
this disease appears to be of high genetic heterogeneity, which
was proven again in this study. Further investigations on large
pedigrees from different genetic backgrounds may help reveal
the  genetic  etiology  of  microphthalmia  [22]  and  map  the
phenotype  to  one  member  of  the  genes  that  direct  eye
development.
Furthermore, a LOD score of less than 1 with all 23
markers involved did not support any linkage relation in this
study, so we excluded the linkage of microphthalmia in this
pedigree with the reported candidate genes (CHX10, PAX6,
and MFRP) and loci (chromosomes 14q32, 11p, and 2q11-
q14). To further identify the gene responsible for this Chinese
family, a whole-genome scan analysis is needed. A novel
locus is predicted to be responsible for the microphthalmia in
this family.
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